•
Jun 30, 2023

IGM Biosciences Q2 2023 Earnings Report

Total Revenue
$448K
Previous year: $366K
+22.4%
EPS
-$1.43
Previous year: -$1.33
+7.5%
R&D Expenses
$55.7M
G&A Expenses
$13M
Cash and Equivalents
$151M
Previous year: $221M
-31.9%
Free Cash Flow
-$57M
Previous year: $109M
-152.1%
Total Assets
$481M
Previous year: $582M
-17.4%

IGM Biosciences

IGM Biosciences

IGM Biosciences Revenue by Segment